Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-5632 in Adults with Elevated Lipoprotein(a) at High Cardiovascular Risk
NCT07185776Phase 2Active, not recruiting
- Sponsor
- Fujian Shengdi Pharmaceuticals
- Start
- Oct 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-5632 in Hyperlipoproteinemia a, sponsored by Fujian Shengdi Pharmaceuticals. Started Oct 2025; status: active, not recruiting.
02
Drugs
HRS-5632
03
Conditions
Hyperlipoproteinemia a
Beyond the preview
Go deeper on NCT07185776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185776.